If you stop, then you cannot reduce your appetite any longer, and you will be hungry, and you will start eating more
The meta-regression analysis suggested that the apparent protective association of GLP-1RAs may emerge relatively early in treatment, a finding consistent with randomized trials reporting improvements in walking capacity after short-term therapy
Similarly, in a retrospective study of 80 patients with metastatic melanoma who received a combined CTLA-4 and a PD-1 inhibitor, patients who developed irAEs warranting treatment discontinuation were later rechallenged with a single-agent PD-1 inhibitor
Key findings from the new studies: ARTIOS trial: Patients who switched to Kesimpta after experiencing relapses or MRI activity on other oral treatments showed fewer relapses, suppressed MRI activity, and over 90% achieved no evidence of disease activity (NEDA-3)
S., Miller, E., Bud, Z., Corella, S
Pregnancy and breastfeeding Semaglutide is contraindicated in pregnancy